Tirzepatide is a dual GIP and GLP-1 receptor agonist. It has achieved considerable interest as a treatment for type-2 diabetes and symptoms related to besity. This medicine helps control blood glucose (or sugar) and lowers hunger/cravings. Tirzepatide is sold under brand names Mounjaro and Zepbound. As more people use this medication, many are asking a critical question: does Tirzepatide cause cancer?
Risk of Cancer Associated with Tirzepatide
The risk of cancer, with respect to thyroid cancer, comes from research on animals that have yet to be tested on humans. These studies determined that animals given Tirzepatide injections were more likely to have medullary thyroid cancer (MTC). How closely these studies are linked to humans is yet to be determined.
Does Tirzepatide Cause Cancer?
The FDA states that Tirzepatide contains a boxed warning about the possible occurrence of thyroid C-cell cancers. To date, there is no proof from human trials that Tirzepatide causes thyroid cancer. The FDA further states that those who have a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use this medication.
What Clinical Trials Show?
SURPASS and SURMOUNT are two large clinical studies that have examined how effective and safe Tirzepatide works. Tirzepatide has not been linked to an increased risk of cancer in any clinical studies. Possible long-term issues are tracked by ongoing post-marketing surveillance. Nevertheless, at this time, there is insufficient data to support the claim that Tirzepatide causes cancer in human subjects. It should be mentioned that similar studies have been conducted on other GLP-1 receptor agonists, namely Semaglutide. It is recommended to keep an eye on thyroid health. The danger is theoretical unless there are specific risk factors.
Should you be concerned?
If you are thinking about using weight loss injections to help you lose weight or control your diabetes, consult your physician about your underlying conditions or if you have a family history of thyroid cancer. SlimNow MD and other healthcare professionals who provide medically supervised weight loss programs thoroughly check the medical histories of their clients to ensure patient safety. When prescribed correctly, Tirzepatide is a valuable tool for improving long-term health.
The Bottom Line
Does Tirzepatide cause cancer?
There is no substantial evidence that Tirzepatide leads to cancer. However, certain high-risk groups should be vigilant. Under proper physician supervision, most individuals can safely use this drug. Prior to starting any treatment plan, consult your physician.
Click here to get the safest, customized lipotropic B12 therapy.